News

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced a cooperative agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS) Office of the Assistant Secretary...

Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). The dedicated Non-GMP formulation development space, which is co-located within the same facility as Alcami's parenteral manufacturing...

Moderna chose Kenya as its location for a $500 million African mRNA vaccine manufacturing effort. The pharmaceutical company says it signed a letter of understanding with Kenyan officials to develop a cutting-edge mRNA plant, that was first announced in...

Bristol Myers Squibb announced that the U.S. FDA approved Opdivo®(nivolumab) 360 mg (injection for intravenous use) in combination with platinum-doublet chemotherapy every three weeks for three cycles for adult patients with resectable (tumors ≥4 cm or node positive) non-small...

Targovax ASA, a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, and Agenus, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today...

Much of the reaction to President Joe Biden's State of the Union address concentrated on the president's repeated calls for Congress to allow Medicare to negotiate medication prices. That is why bringing prices under control was his top concern, Biden stated...

The UK government has put forth its intention to invest £260 million in cutting-edge medical research and development, as well as the manufacturing of innovative pharmaceuticals, gadgets, and diagnostics. Through digital clinical trial services and Trusted Research Environments, the Department of...